latest news

What's New At Isto.

September 29, 2017
Isto Biologics Sponsors Preceptorship on Autologous Therapy in Lower Extremity Orthopedics and Neurologic Procedures

Isto Biologics’ Medical Education team recently supported a biologics Hospital-Based Observation Preceptorship led by Dr. Edgardo Rodriguez, DPM.

February 23, 2017
Isto Medical Education Team Facilitates Training Course in Bone Marrow Aspiration & Autologous Therapy Techniques

Isto Biologics’ Medical Education team recently supported a cadaver lab led by Dr. Blake Johnson, Medical Director at CDI – Twin Cities MN.

June 13, 2016
Thompson Street Capital Partners Acquires ISTO Technologies’ Commercial Business

Thompson Street Capital Partners (TSCP), a private equity firm based in St. Louis with $1.5 billion of assets under management, announced today that it has acquired the commercial operations of ISTO Technologies (ISTO) headquartered in St. Louis, MO.

Tags
© Isto Biologics 2023
SolutionsInQuMagellanInflux FibrantInfluxInflux PLUSInflux SPARCInflux SpongeInforceLightning NeedleBlood Management 
Our companyAboutLeadershipNews & EventsCareers
ResourcesResource CenterPublicationsReferencesComplianceSitemapPrivacy PolicyLegal Disclaimer
AudienceFor PhysiciansFor Hospital AdministratorsFor Distributors
Contact UsContact PageRequest A QuoteFind A Local RepCall Us Today
Isto Biologics is the trade name of a single integrated business group that operates through a number of subsidiaries that includes Arteriocyte Medical Systems, Inc., Isto Technologies II, LLC, Progenicare, LLC, Progenicare Therapeutics, LLC, and Advanced Transfusion Services, LLC.